Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in a Single Institute in North Africa over the Last 16 Years
Introduction: Because of the low incidence, nonspecific symptoms at presentation, lack of awareness, and non-uniform classifications, gastroenteropancreatic neuroendocrine tumors (GEP-NETs) remains a poorly understood disease, and delayed diagnosis is common among patients with GEP-NETs.
Aim(s): The aim of our study was to determine survival characteristic of patients with GEP-NETs in Tunisia.
Materials and methods: Data on all patients diagnosed with GEP-NET at the medical oncology department of Salah Azaiez Institute in Tunisia between January 2002 and January 2019 were collected retrospectively. Overall survival (OS) were evaluated independently of tumors stage.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: YAHYAOUI Y
To read the full abstract, please log into your ENETS Member account.